Skip to main content

Table 2 The dynamic changes of chromatin remodeling modification/factors in neurodegenerative diseases

From: Small molecule modulators of chromatin remodeling: from neurodevelopment to neurodegeneration

Neurodegenerative diseases

Chromatin remodeling modification/factors

Changes in Diseases

References

Alzheimer’s disease (AD)

H4 acetylation

Decreased

[166,167,168]

H3K27ac

Global increased

[169]

H3K9me2

Increased

[177]

DNA methylation

Not certain

[207, 210, 211]

HDAC1

Decreased

[174]

HDAC2

Increased

[230]

HDAC3

Increased

[172, 173]

HDAC6

Increased

[171]

EHMT1

Increased

[177]

Parkinson’s disease (PD)

H3K14ac

Increased

[182]

H3K18ac

Increased

[182]

HDAC2

Increased

[231]

Huntington’s disease (HD)

H3K9me3

Increased

[188]

H3K4me3

Decreased

[189]

HDAC1

Increased

[193]

HDAC2

Increased

[232]

HDAC3

Increased

[192, 193]

HDAC4

Increased

[194]

H2AFY

Increased

[195]

Amyotrophic lateral sclerosis (ALS)

H3K14ac

Decreased

[196]

H3K56ac

Decreased

[196]

H4K12ac

Increased

[196]

H4K16ac

Increased

[196]

HDAC11

Decreased

[197]

HDAC2

Increased

[197]

H2B Thr129 and Ser10 phosphorylation

Decreased

[196]

H3 Thr129 and Ser10 phosphorylation

Decreased

[196, 200]

Amyotrophic lateral sclerosis (ALS)

H3K9me3

Increased

[201]

H3K27me3

Increased

[201]

H4K20me3

Increased

[201]

H2A K119 ubiquitination

Decreased

[202]

DNMT1

Increased

[214]

DNMT3a

Increased

[214]

Mitochondrial DNA methylation

Increased

[216]

CHD1

Decreased

[221]

CHD2

Decreased

[221]

nBAF

Decreased

[224]